Daily non-political popular news in brief.

International studies show high efficacy for HPV vaccine

A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus responsible for most cases of cervical cancerÑstrains 16 and 18. Researchers combined and analyzed the data from four randomized trials that involved 20,583 women ages 15 to 26 from more than two dozen countries. Researchers found that the prophylactic administration of the vaccine was highly effective in preventing pre-malignant changes of the cervix.

Read more »

Keywords: international, studies, show, efficacy, hpv, vaccine, study

« Previous | Next »

Similar news on "International studies show high efficacy for HPV vaccine":

1. Study shows continued success for new HPV vaccine against virus responsible for cervical cancer
   05-09-2007 · EurekAlert!
   A new vaccine aimed at preventing cervical cancer is nearly 100 percent effective against the two types of the human papillomavirus responsible for most cases of cervical cancer. Researchers at more than a dozen international medical centers evaluated the efficacy of quadrivalent vaccine targeting HPV types 6, 11, 16 and 18 in more than 12,000 women ages 15 to 26 in 13 countries for nearly three years. They found a near 100 percent efficacy rate in prevention of HPV types 16 and 18.
   Similar news · Read more »
   
2. Study shows interruption of antiretroviral therapy increases risk of disease and death
   11-30-2006 · EurekAlert!
   Findings from one of the largest HIV/AIDS therapy studies show that a specific strategy of interrupting antiretroviral therapy more than doubles the risk of AIDS or death from any cause. Researchers affiliated with the Mailman School of Public Health led a large multi-center international study, known as Strategies for Management of Anti-Retroviral Therapies, or SMART, comparing two treatment strategies for people with human immunodeficiency virus. Findings demonstrate the value of continuous antiretroviral therapy.
   Similar news · Read more »
   
3. New studies on goats' milk show it is more beneficial to health than cows' milk
   07-30-2007 · EurekAlert!
   It helps to prevent diseases such as anemia and bone demineralization. UGR researchers have carried out a comparative study on the properties of goats' milk compared to those of cows’ milk. Rats with induced nutritional ferropenic anemia have been used in the study. Goats' milk helps digestive and metabolic utilization of minerals such as iron, calcium, phosphorus and magnesium. Part of the results of this research have been published in the prestigious scientific journals International Dairy Journal and Journal Dairy Science.
   Similar news · Read more »
   
4. Effectiveness of over-the-counter decongestant questioned in new study
   01-31-2007 · EurekAlert!
   The only over-the-counter (OTC) oral decongestant currently available without restriction may be less effective than previously thought, according to a new study. This meta-analysis of 15 previous studies concludes that the standard 10 mg dose of the drug, found in popular products such as Actifed, Sudafed PE, and Tylenol Sinus, appears to be no more effective than placebo and suggests that the FDA should require additional studies to prove the drug's safety and efficacy.
   Similar news · Read more »
   
5. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
   08-14-2007 · EurekAlert!
   For women with human papillomavirus infection, use of the HPV-16/18 vaccine will not accelerate reduction of the virus and should not be used to treat the infection, according to a study in the Aug. 15 issue of JAMA.
   Similar news · Read more »
   
6. Penn's Abramson Cancer Center part of major phase III study for myeloma
   11-21-2007 · EurekAlert!
   Researchers from the UPenn's Abramson Cancer Center announced today that findings from two international clinical trials show unprecedented survival for patients with myeloma, a cancer the blood-making cells of bone marrow. Findings show that with the oral drug lenalidomide, in combination with dexamethasone, patients significantly improved by all measures where previous treatments had failed -- including a median survival of nearly three years -- the longest median survival known for this difficult to treat patient group.
   Similar news · Read more »
   
7. Study demonstrated AMITIZA (lubiprostone) showed efficacy
   10-23-2006 · EurekAlert!
   Results of a secondary analysis of two pivotal studies were presented today at the 71st Annual Meeting of the American College of Gastroenterology (ACG), and showed that 60 percent of patients treated with AMITIZA (TM) (lubiprostone) experienced a spontaneous bowel movement (SBM) within 24 hours of treatment, and 80 percent experienced a SBM within 48 hours of treatment.
   Similar news · Read more »
   
8. Mayo Clinic study finds heart transplant patients benefit from new approach to immunosuppression
   04-26-2007 · EurekAlert!
   A new immunosuppression regimen for heart transplant patients can improve kidney function and prevent transplant coronary artery disease, according to two new Mayo Clinic studies. Mayo researchers will report their findings on April 26 at the International Society for Heart & Lung Transplantation Annual Meeting and Scientific Session in San Francisco.
   Similar news · Read more »
   
9. Promising Phase 3 trial results show biologic therapy ustekinumab significantly improved psoriasis
   10-03-2007 · EurekAlert!
   The first reported findings from an international, Phase 3 study showed that more than two-thirds of patients with moderate to severe plaque psoriasis receiving two doses of ustekinumab (CNTO 1275) achieved at least a 75 percent reduction in psoriasis at week 12, the primary endpoint of the study, as measured by the Psoriasis Area and Severity Index.
   Similar news · Read more »
   
10. IMS updated recommendations on postmenopausal hormone therapy
    05-16-2007 · EurekAlert!
    The Updated Recommendations express the views of the International Menopause Society on the principles of hormone therapy in the peri- and postmenopausal periods. New data and re-analyses of older studies by women's age show that, for most women, the potential benefits of hormone therapy given for a clear indication are many and the risks are few when initiated within a few years of menopause.
    Similar news · Read more »